Skip to content
The Policy VaultThe Policy Vault

tazarotene (Tazorac) — Point32Health

plaque psoriasis

Initial criteria

  • Patient age ≥ 26 years
  • Documented diagnosis of plaque psoriasis OR basal cell carcinoma OR early stage mycosis fungoides